Ex Parte MURLEY et al - Page 4



              Appeal No. 2003-0934                                                                     Page 4                 
              Application No. 08/769,596                                                                                      
                      According to the examiner, Rosenthal “teach[es] that chondroitin sulfate and                            
              animal protein are known to be useful for wound healing.”  Paper no. 13, page 4.  While                         
              Rosenthal does teach that “all collagen types, tenascin, laminin, chondroitin sulfate,                          
              hyaluronic acid, dermatan sulfate, heparin sulfate, heparin, elastin, fibrin, fibronectin,                      
              vitronectin, dextran, or oxidized regenerated cellulose” are suitable materials “for use in                     
              the repair of full and partial thickness defects of the skin,” the materials are used in the                    
              form of a freeze-dried, bioabsorbable “fibrous mass,” “sponge” or “film” which “is readily                      
              invaded by cells of the host organism,” and which is “strong and resilient enough to                            
              resist collapse and may be cut and/or formed so as to conform to a wound shape so                               
              that it protects and/or fills a wound bed.”  Column 2, lines 37-48; and column 3, lines 1-                      
              38.  The examiner has not explained how or why Rosenthal’s teachings would have led                             
              one skilled in the art to include chondroitin sulfate and animal protein as integral                            
              components of a viscous, but flowable gel, and in a comparatively minor amount (about                           
              0.1%).                                                                                                          
                      As explained in In re Kotzab, 217 F.3d 1365, 1369-70, 55 USPQ2d 1313, 1316                              
              (Fed. Cir. 2000):                                                                                               
                      A critical step in analyzing the patentability of claims pursuant to section                            
                      103(a) is casting the mind back to the time of invention, to consider the                               
                      thinking of one of ordinary skill in the art, guided only by the prior art                              
                      references and the then-accepted wisdom in the field. [ ] Close adherence                               
                      to this methodology is especially important in cases where the very ease                                
                      with which the invention can be understood may prompt one “to fall victim                               
                      to the insidious effect of a hindsight syndrome wherein that which only the                             
                      invention taught is used against its teacher.” [ ]                                                      
                      . . . to establish obviousness based on a combination of the elements                                   
                      disclosed in the prior art, there must be some motivation, suggestion or                                
                      teaching of the desirability of making the specific combination that was                                
                      made by the applicant.  [citations omitted]                                                             
                      In other words, “there still must be evidence that ‘a skilled artisan, . . . with no                    
              knowledge of the claimed invention, would select the elements from the cited prior art                          


Page:  Previous  1  2  3  4  5  Next 

Last modified: November 3, 2007